4//SEC Filing
MacDermott Kevin 4
Accession 0001654954-22-007147
CIK 0001644903other
Filed
May 17, 8:00 PM ET
Accepted
May 18, 4:06 PM ET
Size
7.8 KB
Accession
0001654954-22-007147
Insider Transaction Report
Form 4
cbdMD, Inc.YCBD
MacDermott Kevin
President
Transactions
- Award
Common Stock
2022-05-16+125,000→ 126,000 total - Award
Common Stock (Right to Buy)
2022-05-16+405,000→ 405,000 totalExercise: $0.84Exp: 2022-05-16→ Common Stock (405,000 underlying)
Footnotes (2)
- [F1]Represents restricted stock units. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. The grant was exempt from Section 16(b) under the Securities Exchange Act of 1934 by virtue of Rule 16b-3 promulgated thereunder as it was approved in advance by the Issuer's Compensation, Corporate Governance and Nominating Committee, which is comprised of four non-employee directors. The restricted stock units were issued under the 2021 Equity Compensation Plan as partial compensation to the Reporting Person for his services as the Issuer's President beginning May 16, 2022.
- [F2]The stock options were granted under the 2021 Equity Compensation Plan as compensation to the Reporting Person as the Issuer's President beginning May 16, 2022. The grant was exempt from Section 16(b) under the Securities Exchange Act of 1934 by virtue of Rule 16b-3 promulgated thereunder as it was approved in advance by the Issuer's Compensation, Corporate Governance and Nominating Committee, which is comprised of three non-employee directors. The options vest annually in three equal increments on May 15, 2023, May 15, 2024, and May 15, 2025.
Documents
Issuer
cbdMD, Inc.
CIK 0001644903
Entity typeother
Related Parties
1- filerCIK 0001928755
Filing Metadata
- Form type
- 4
- Filed
- May 17, 8:00 PM ET
- Accepted
- May 18, 4:06 PM ET
- Size
- 7.8 KB